Literature DB >> 26182301

Patient Demands and Requests for Cancer Tests and Treatments.

Keerthi Gogineni1, Katherine L Shuman2, Derek Chinn2, Nicole B Gabler3, Ezekiel J Emanuel4.   

Abstract

IMPORTANCE: Surveyed physicians tend to place responsibility for high medical costs more on "demanding patients" than themselves. However, there are few data about the frequency of demanding patients, clinical appropriateness of their demands, and clinicians' compliance with them.
OBJECTIVE: To assess how frequently patients demand or request medical tests or treatments, what types they demand, the clinical appropriateness of their demands, and how frequently clinicians comply. DESIGN, SETTING, AND PARTICIPANTS: Immediately after visits, clinicians--physicians, fellows, nurse practitioners, and physician assistants--were interviewed about whether the patient made a demand or request and their type and appropriateness. Interviews occurred in oncology outpatient facilities at 3 Philadelphia-area hospitals between October 2013 and June 2014. MAIN OUTCOMES AND MEASURES: The 4 main outcomes were (1) frequency of patient demands for medical tests or treatments, (2) the types of tests or treatments demanded, (3) clinicians' assessment of the clinical appropriateness of the demands, and (4) how frequently clinicians complied.
RESULTS: There were 5050 patient-clinician encounters involving 3624 patients and 60 clinicians. Overall, of the 5050 encounters, 440 (8.7%) included a patient demand or request for a medical intervention. Clinicians complied with 365 of the clinically appropriate demands (83.0%). In only 50 of the 440 encounters with demands (11.4%) did the patient demand or request clinically inappropriate interventions. Clinicians complied with 7 of these inappropriate demands or requests (14%). Clinicians complied with inappropriate demands or requests in only 0.14% (7 of 5050) of encounters. Of the 440 patient demands, 216 (49.1%) were for imaging studies; 68 (15.5%) were for palliative treatments, excluding chemotherapy or radiation; and 60 (13.6%) were for laboratory tests. In a multivariable model, having lung/head and neck cancer (odds ratio [OR], 1.74; 95% CI, 1.26-2.41), receiving active treatments (OR, 1.40; 95% CI, 1.11-1.77), and a fair- or poor-quality patient-clinician relationship (OR, 2.82; 95% CI, 1.13-7.07) were associated with patients making demands or requests (all P < .01). CONCLUSIONS AND RELEVANCE: Patient demands occur in 8.7% of patient-clinician encounters in the outpatient oncology setting. Clinicians deem most demands or requests as clinically appropriate. Clinically inappropriate demands occur in 1% of encounters, and clinicians comply with very few. At least in oncology, "demanding patients" seem infrequent and may not account for a significant proportion of costs.

Entities:  

Mesh:

Year:  2015        PMID: 26182301     DOI: 10.1001/jamaoncol.2014.197

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  14 in total

1.  Analysis of Physician Variation in Provision of Low-Value Services.

Authors:  Aaron L Schwartz; Anupam B Jena; Alan M Zaslavsky; J Michael McWilliams
Journal:  JAMA Intern Med       Date:  2019-01-01       Impact factor: 21.873

2.  Dynamic Assessment of Value During High-Cost Cancer Treatment: A Response to American Society of Clinical Oncology and European Society of Medical Oncology.

Authors:  Charles W Given; Barbara A Given; Cathy J Bradley; John C Krauss; Alla Sikorskii; Eric Vachon
Journal:  J Oncol Pract       Date:  2016-10-31       Impact factor: 3.840

3.  Changes in Low-Value Services in Year 1 of the Medicare Pioneer Accountable Care Organization Program.

Authors:  Aaron L Schwartz; Michael E Chernew; Bruce E Landon; J Michael McWilliams
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

4.  Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer.

Authors:  Jinhai Huo; Yiyi Chu; Karim Chamie; Marc C Smaldone; Stephen A Boorjian; Jacques G Baillargeon; Yong-Fang Kuo; Preston Kerr; Padraic O'Malley; Eduardo Orihuela; Douglas S Tyler; Stephen J Freedland; Sharon H Giordano; Raghu Vikram; Ashish M Kamat; Stephen B Williams
Journal:  Clin Genitourin Cancer       Date:  2017-07-26       Impact factor: 2.872

5.  Perceptions of patients and providers on myocardial perfusion imaging for asymptomatic patients, choosing wisely, and professional liability.

Authors:  Kristopher P Kline; Leslee Shaw; Rebecca J Beyth; Jared Plumb; Linda Nguyen; Tianyao Huo; David E Winchester
Journal:  BMC Health Serv Res       Date:  2017-08-11       Impact factor: 2.655

6.  Exploring factors that might influence primary-care provider discussion of and recommendation for prostate and colon cancer screening.

Authors:  Christine E Kistler; Maihan Vu; Anne Sutkowi-Hemstreet; Ziya Gizlice; Russell P Harris; Noel T Brewer; Carmen L Lewis; Rowena J Dolor; Colleen Barclay; Stacey L Sheridan
Journal:  Int J Gen Med       Date:  2018-05-17

7.  Getting (Along) With the Guidelines: Reconciling Patient Autonomy and Quality Improvement Through Shared Decision Making.

Authors:  Yan Xu; Philip S Wells
Journal:  Acad Med       Date:  2016-07       Impact factor: 6.893

8.  A survey of primary care patients' readiness to engage in the de-adoption practices recommended by Choosing Wisely Canada.

Authors:  William Silverstein; Elliot Lass; Karen Born; Anne Morinville; Wendy Levinson; Cara Tannenbaum
Journal:  BMC Res Notes       Date:  2016-06-10

9.  Medical overuse and quaternary prevention in primary care - A qualitative study with general practitioners.

Authors:  Kathrin Alber; Thomas Kuehlein; Angela Schedlbauer; Susann Schaffer
Journal:  BMC Fam Pract       Date:  2017-12-08       Impact factor: 2.497

10.  Association of Low-Value Care Exposure With Health Care Experience Ratings Among Patient Panels.

Authors:  Prachi Sanghavi; J Michael McWilliams; Aaron L Schwartz; Alan M Zaslavsky
Journal:  JAMA Intern Med       Date:  2021-07-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.